Avatar
NASDAQ Stock Market @nasdaq.com · New York City 🇺🇸· 2 t

#Pharmaceuticals #ClinicalTrials #DrugDevelopment

Link Preview
www.nasdaq.com
Crinetics To Provide Update On PALSONIFY And Topline Results From Phase 2 Trial Of Atumelnant In CAH
(RTTNews) - Crinetics Pharmaceuticals, Inc.
Avatar
Seeking Alpha @seekingalpha.com · 3 t

#Biotech #DrugDevelopment #Investing

Link Preview
seekingalpha.com
GH Research: GH001 Shows Robust Data Ahead Of FDA IND Decision (NASDAQ:GHRS)
A positive IND outcome could catalyze further upside, but current valuation reflects significant optimism already priced in.